Viruses of avian origin demonstrate potential for cancer virotherapy
Authors:
- 21 February 2026
- journal article
- research article
- Published by Springer Nature in Archives of Virology
- Vol. 171 (3) , 86
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- This research was funded internally by MIGAL institute
This publication has 47 references indexed in Scilit:
- Oncolytic virus-based combination therapy in breast cancerCancer Letters, 2024
- Oncolytic virus preclinical toxicology studiesJournal of Applied Toxicology, 2022
- Development of oncolytic viruses for cancer therapyTranslational Research, 2021
- Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenovirusesPorto Biomedical Journal, 2018
- Optimized polypeptide for a subunit vaccine against avian reovirusVaccine, 2016
- Wide-range protection against avian reovirus conferred by vaccination with representatives of four defined genotypesVaccine, 2011
- Field avian Metapneumovirus evolution avoiding vaccine induced immunityVaccine, 2010
- The immunologic aspects of poxvirus oncolytic therapyCancer Immunology, Immunotherapy, 2009
- Avian reovirus: Structure and biologyVirus Research, 2007
- Phase I/II Trial of Intravenous NDV-HUJ Oncolytic Virus in Recurrent Glioblastoma MultiformeMolecular Therapy, 2006